ACP5 and diabetes mellitus: While multiple reports have indicated that bone resorption marker levels such as CTX, TRAcP5b, DPD, and NTX are similar or higher in diabetic patients than in controls [8], a recent meta-analysis has shown a marked decline in bone resorption marker rates such as CTX and TRAcP5b relative to patients without diabetes [14].